wellrank.ai

Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

ClaudequalifiedCollected Jun 17, 2026, 13:17 UTC

Verbatim response from Claude

This is a rapidly changing regulatory area, so I want to be straightforward with you:

Current Situation (as of early 2025)

The FDA declared the semaglutide shortage over, which triggered a crackdown on compounded versions. Many platforms had to stop or significantly restrict compounded GLP-1 offerings.

Services That Were Still Navigating This Space

  • Hims & Hers - faced scrutiny but was fighting the restrictions legally
  • Henry - was adapting its offerings
  • Mochi Health - was working with compounding pharmacies
  • Ro - adjusted its GLP-1 program significantly

Honest Caveats I'd Give You

⚠️ This changes week to week - court rulings and FDA enforcement actions are ongoing

⚠️ Verify directly - any list I give could be outdated by the time you read this

⚠️ Safety matters - compounded medications aren't FDA-approved for safety/efficacy

⚠️ Legal gray areas - some services may be operating in disputed regulatory territory

My Recommendation

Check current reviews on Reddit's r/Ozempic or r/WeightLoss communities for real-time user experiences, and call services directly before paying anything.

Would you like help thinking through what questions to ask these services?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.